Thymulin

What is Thymulin?

Thymulin (Facteur Thymique Sérique — Serum Thymic Factor) is a nine-amino acid peptide produced exclusively by thymic epithelial cells and requires a zinc cofactor to be biologically active. It was discovered in the 1970s and has since been studied as a key mediator of thymic immune education.

Thymulin levels decline dramatically with age — correlating with thymic involution (the age-related shrinkage of the thymus) that occurs after puberty. By age 60, thymulin plasma levels are approximately 10% of peak youthful levels — a decline that correlates with the reduced immune function of aging.

Mechanism of Action

T-Cell Differentiation

Thymulin facilitates several critical steps in T-cell maturation within the thymus: expression of T-cell surface markers (CD4, CD8), development of self-tolerance, and final maturation into effector-competent T-cells.

Anti-Inflammatory Signaling

Beyond T-cell education, thymulin modulates systemic inflammation — reducing pro-inflammatory cytokine production and balancing Th1/Th2 immune responses. This anti-inflammatory activity may be relevant to autoimmune disease research.

Neuroendocrine Interactions

Thymulin has documented interactions with the neuroendocrine system — with receptors found in the brain and bidirectional signaling with cortisol, GH, and sex hormones. This neuroendocrine bridge positions thymulin in longevity research at the intersection of immune and endocrine aging.

Key Research Findings

Thymulin levels correlate inversely with autoimmune disease activity and directly with immune competence in aging studies. Animal longevity research shows beneficial effects on lifespan and immune function. In pain research, thymulin demonstrates analgesic effects through central mechanisms. Combined with Thymosin Alpha-1, thymulin provides complementary immune modulation covering different aspects of T-cell biology.

*For research use only. Not for human consumption.*